glp 1 chemical structure The GLP-1 weight loss revolution | Feature PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Oral semaglutide is a tool, not a magic wand

Its a very common side effect because people often maximize their dose to try to achieve target weight goals quickly, Dr

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) begin affecting appetite and blood sugar within days to weeks, but clinically meaningful outcomes develop more gradually

So far, the most common side effects seen in clinical trials have been digestive symptoms, such as nausea, vomiting, diarrhoea, constipation, bloating, burping and indigestion

Preliminary results indicate that such drugs might not only be effective for obesity and diabetes but also for a number of other diseases including osteoarthritis, Parkinson's disease and a range of conditions caused by a buildup of fat in the liver, known as nonalcoholic steatohepatitis (NASH) (Brandt, Mller, DiMarchi)

The Bottom Line Retatrutide causes diarrhea in 16-34% of users, depending on dose